Metraipolis › archive › dc_af3eda45909f

Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report — Europe PMC PMID:41030252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41030252
DOI
10.3389/fmed.2025.1667519
License (as archived)
solo-consultazione
Archived
2026-11-09T22:57:27.278Z
SHA-256 of the archived text
eb1611bfebe62cecf684a762d866f666adb604e9d3e64c22a4de96c25de9534e
Stable URL of this page
https://metraipolis.com/documento/dc_af3eda45909f

How to cite

Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report — Europe PMC PMID:41030252 — Europe PMC (en), https://europepmc.org/article/MED/41030252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af3eda45909f (Metraipolis archive dc_af3eda45909f, sha256 eb1611bfebe62cecf684a762d866f666adb604e9d3e64c22a4de96c25de9534e)
BibTeX
@misc{dcaf3eda45909f,
  title = {Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report — Europe PMC PMID:41030252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41030252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af3eda45909f; sha256 eb1611bfebe62cecf684a762d866f666adb604e9d3e64c22a4de96c25de9534e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030252. Agents can read the archived copy with the MCP tool read_document.